Horizon Therapeutics plc Partners with the Doug the Pug Foundation and Sing Me A Story Foundation to Bring Awareness to Rare Diseases Impacting Children through #RAREis Playlist
Horizon Therapeutics has partnered with the Doug the Pug Foundation and Sing Me A Story Foundation to launch the #RAREis Playlist program, focusing on children with rare diseases. The initiative aims to amplify their voices through storytelling and music. Leanor, a 7-year-old with Ewing sarcoma, inspired a new song titled 'The Quest for the Golden Pearl'. The music video will premiere on February 17, followed by a social media challenge on February 20. This program has evolved since 2017 to provide resources for families navigating rare diseases.
- Launch of #RAREis Playlist program, enhancing community engagement.
- Collaboration with prominent nonprofits amplifying children's voices.
- Directly involves a child with Ewing sarcoma in a creative format.
- Ewing sarcoma only affects 200 youths annually in the U.S., indicating limited market scope.
-- The original song inspired by a creative story written by Leanor, a 7-year-old who lives with a rare pediatric cancer --
-- The Doug the Pug and #RAREis Playlist music video will premiere
According to the
Leanor was selected by the Doug the
Diagnosed with
“For Leanor to have this opportunity to see a story she and her sister wrote come to life by her favorite pug celebrity is magical,” said Aimee F., Leanor’s mother. “Her story is just like her, full of imagination and a bright light of happiness.”
The Doug the
“Doug has a special way of putting a smile on people’s faces and that’s why we launched the Foundation because bringing joy to kids like Leanor, and allowing them to explore their own creativity, is so special,” said
“Leanor’s song featured in a unique social media challenge and the partnership with the Doug the
The #RAREis Playlist program, founded by Horizon in partnership with Sing Me A Story in 2018, features more than 50 stories written by children impacted by rare diseases and accompanying songs created by musical artists.
To hear Leanor’s story, visit the RAREisPlaylist.com website. #RAREis will launch the full music video on
About #RAREis
In February of 2017, Horizon launched the #RAREis program aimed at elevating the voices, faces and experiences of people living with rare diseases, as well as highlight programs and resources for the rare disease community. The program is anchored by an Instagram page and website that showcases photos and stories of people touched by rare disease and captures elements of their patient, caregiver or advocate experience. To learn more, visit the #RAREis Instagram and Facebook page and visit the website at www.RAREisCommunity.com.
About Horizon
Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.
About Doug the
The Doug the
About
Sing Me a Story creates songs for deserving families in need based on the imaginative stories of their children. To learn more – and hear songs created as part of this process – visit SingMeAStory.org. Follow @SingMeAStory on social media.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220215005414/en/
Horizon contacts:
Sr. Manager,
media@horizontherapeutics.com
Executive Vice President, Corporate Affairs & Chief Communications Officer
media@horizontherapeutics.com
Ireland Media Contact:
Gordon MRM
ray@gordonmrm.ie
Source:
FAQ
What is the #RAREis Playlist program by Horizon Therapeutics?
When will the music video for Leanor's song premiere?
What condition does Leanor have?
What is the purpose of Horizon Therapeutics' partnership with Doug the Pug Foundation?